J Asthma Allergy

J Asthma Allergy

Country: Unknown

Publisher: Unknown

Publication Period: Unknown

386

Papers in Database

Journal Information
Publication Details
Additional Information

Subject Term Count: 1

Last Updated: Aug 05, 2025

Recent Papers

View All 386 Papers
A Retrospective Claims Database Study to Clarify Treatment Reality of Asthma Patients Before and After Referral to a Sp…

Hozawa S, Ono K, Makita N, Uchimura H, Arita Y, Hirai T, Tashiro N.

2024 PMID: 38259253
3/7
COI Funding
Dupilumab Reduces Asthma Disease Burden and Recurrent SCS Use in Patients with CRSwNP and Coexisting Asthma.

Gurnell M, Radwan A, Bachert C, Lugogo N, Cho SH, Nash S, Zhang H, Khan AH, Jacob-Nara JA, Rowe PJ,…

2024 PMID: 38250137
3/7
COI Funding
Inhibitory Effect of Apolipoprotein A-I on Eosinophils in Allergic Rhinitis in vitro and in vivo.

Zeng Y, Li J, Wen Y, Xiao H, Yang C, Zeng Q, Liu W.

2024 PMID: 38370533
3/7
COI Funding
What is the Best Way to Diagnose Possible Asthma Patients with Negative Bronchodilator Reversibility Tests?

Başa Akdoğan B, Koca Kalkan I, Köycü Buhari G, Özdedeoğlu Ö, Ateş H, Aksu K, Öner Erkekol F.

2024 PMID: 38410137
3/7
COI Funding
1-Year Prospective Study of the Relationship of Serial Exhaled Nitric Oxide Level and Asthma Control.

Ko FWS, Chan KP, Ng JKC, Ngai JCL, Yip WH, Lo RLP, Chan TO, Hui DSC.

2023 PMID: 37469451
4/7
COI Funding
Assessment of Anxiety, Depression, and Sleep Quality in Mothers of Children with Atopic Dermatitis: A Qualitative Quest…

Song J, Gao Y, Wang Y, Dai H, Jia X, Xiang Q, Zhang H, Zheng R, Zhang W.

2023 PMID: 37637475
3/7
COI Funding
Assessment of Fraction of Exhaled Nitric Oxide and Soluble Receptor for Advanced Glycation End Products Biomarkers for …

Alzayadneh EM, Al Bdour SA, Elayeh ER, Ababneh MM, Al-Ani RA, Shatanawi A, Al-Iede M, Al-Zayadneh E.

2023 PMID: 37559895
3/7
COI Funding
Asthma and COVID-19 Outcomes: A Prospective Study in a Large Health Care Delivery System.

Finkas LK, Ramesh N, Block LS, Yu BQ, Lee MT, Lu M, Skarbinski J, Iribarren C.

2023 PMID: 37791041
4/7
COI Funding